Nevro Corp Ownership
| NVRO Stock | USD 5.72 0.01 0.17% |
Shares in Circulation | First Issued 2013-09-30 | Previous Quarter 36.9 M | Current Value 37.3 M | Avarage Shares Outstanding 28.7 M | Quarterly Volatility 9.9 M |
Nevro |
Nevro Stock Ownership Analysis
About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.79. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nevro Corp recorded a loss per share of 1.87. The entity had not issued any dividends in recent years. The firm had 1:24 split on the 6th of November 2014. Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California. Nevro Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 945 people. To find out more about Nevro Corp contact DKeith Grossman at 650 251 0005 or learn more at https://nevro.com.Besides selling stocks to institutional investors, Nevro Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Nevro Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Nevro Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Nevro Corp Quarterly Liabilities And Stockholders Equity |
|
Nevro Corp Insider Trades History
Roughly 4.0% of Nevro Corp are currently held by insiders. Unlike Nevro Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Nevro Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Nevro Corp's insider trades
Nevro Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nevro Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nevro Corp backward and forwards among themselves. Nevro Corp's institutional investor refers to the entity that pools money to purchase Nevro Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-12-31 | 769.9 K | Palo Alto Investors, Llc | 2024-12-31 | 750.4 K | Assenagon Asset Management Sa | 2024-12-31 | 670.8 K | Jacobs Levy Equity Management, Inc. | 2024-12-31 | 661.7 K | Western Standard Llc | 2024-12-31 | 645.1 K | Citadel Advisors Llc | 2024-09-30 | 536.1 K | Jpmorgan Chase & Co | 2024-09-30 | 462.2 K | Goldman Sachs Group Inc | 2024-12-31 | 455.1 K | Jefferies Financial Group Inc | 2024-12-31 | 441.9 K | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-12-31 | 4.4 M | Armistice Capital, Llc | 2024-12-31 | 3.7 M |
Nevro Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nevro Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nevro Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nevro Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nevro Corp Outstanding Bonds
Nevro Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nevro Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nevro bonds can be classified according to their maturity, which is the date when Nevro Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Nevro Corp Corporate Filings
| 21st of February 2025 Other Reports | ViewVerify | |
| 20th of February 2025 Other Reports | ViewVerify | |
| 14th of February 2025 Other Reports | ViewVerify | |
8K | 6th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.87) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.